Physician

Afshin Dowlati, MD

According to 2025 Medicare claims, Afshin Dowlati, MD (NPI: 1528084852) practices hematology/oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is UNIVERSITY HOSPITALS MEDICAL GROUP INC (NPI: 1669499414; TIN: 204881619) and primary practice location at 44106-1716. Dowlati is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Dowlati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 367 HCPCS/CPT codes, and received $34,610 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 351 prescription claims across 79 beneficiaries totaling $1,220,222 in drug costs, led by Tagrisso (Osimertinib Mesylate). DME data shows 11 claims. Open Payments data shows 337 records totaling $10,372,838. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $678,473 and ending at $1,220,222. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $940 and ending at $975.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	147	506	$33,909
2016	192	654	$40,658
2017	178	800	$73,464
2018	185	669	$65,959
2019	174	524	$44,306
2020	152	463	$37,134
2021	155	418	$41,897
2022	152	432	$42,761
2023	130	355	$34,110
2024	139	367	$34,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	415	$678,473
2016	96	473	$1,152,906
2017	81	360	$1,249,581
2018	68	267	$983,815
2019	89	337	$431,362
2020	84	301	$258,800
2021	81	253	$408,788
2022	67	231	$859,023
2023	71	191	$333,428
2024	79	351	$1,220,222

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$727
2017	N/R	11	$734
2018	N/R	32	$1,283
2019	N/R	16	$177
2020	N/R	N/R	N/R
2021	N/R	26	$1,120
2022	N/R	58	$2,453
2023	N/R	24	$925
2024	N/R	11	$808

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	26	26	$138
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	82	211	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	79	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	11	22	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tagrisso	Osimertinib Mesylate	30	900	$501,766
Alecensa	Alectinib Hcl	15	470	$269,771
Lumakras	Sotorasib	13	390	$153,470
Ondansetron Hcl	Ondansetron Hcl	45	499	$2,250
Prochlorperazine Maleate	Prochlorperazine Maleate	50	449	$535

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$808

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$5,399	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	329	$10,367,439	UH CLEVELAND MEDICAL CENTER
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Afshin Dowlati, MD?

Tedicare shows public-source Medicare data for Afshin Dowlati, MD (NPI 1528084852), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afshin Dowlati, MD have ACO affiliation data?

Afshin Dowlati, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Afshin Dowlati, MD?

Afshin Dowlati, MD is linked to UNIVERSITY HOSPITALS MEDICAL GROUP INC (billing NPI 1669499414) in the available physician profile data.

Does Afshin Dowlati, MD have Open Payments data?

Afshin Dowlati, MD has 337 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.